Post-IPO Equity Therapeutics Companies

Onward develops an Implantable Neuro-stimulation System (INS) with real-time motion feedback and uses training tools.

Acurx Pharmaceuticals is a clinical stage biopharmaceutical company focused on developing new antibiotics for difficult to treat infections.

MeiraGTx is a biotechnology company that focuses on developing gene therapies to treat inherited and acquired genetic disorders.

Spyre Therapeutics is a biotechnology business that is developing a strong pipeline of antibody therapies.

Cadrenal Therapeutics develops a late-stage novel therapy for patients with end-stage renal disease and atrial fibrillation.

Gritstone bio is a biotechnology company that develops immunotherapies for cancer and infectious diseases.

Rallybio is an biotechnological research and development services intended to transform the lives of patients with a devastating disease.

Korro Bio provides an efficient and selective method for RNA editing, leveraging natural processes common to all multi-cellular organisms.

Defence Therapeutics is a scientific pioneer on a journey to uncover enhanced treatment solutions for future generations.

Calidi Biotherapeutics is a clinical-stage biotechnology company developing immunotherapies for cancer.

Akero Therapeutics is a biotechnology company focused on reversing the NASH epidemic by restoring the body’s metabolism to a balanced state.

Dermata Therapeutics is a biotechnology firm that focuses on advancements in the treatment of serious diseases treated by dermatologists.

Calithera Biosciences is a pharmaceutical company developing novel small molecule therapeutics for the treatment of cancer.

Palisade Bio is a clinical-stage biopharmaceutical company that develops therapies for acute and chronic gastrointestinal complications.

OnKure is a clinical-stage biopharma company developing precision medicines targeting validated cancer drivers.

Stoke is developing antisense oligonucleotide medicines that target RNA splicing to increase gene expression for treatment.

MAIA Biotechnology is a clinical-stage biopharmaceutical company developing cancer therapies that target telomeres through immunotherapy.

Stimcell Energetics is a biotechnology company that focuses on the discovery, development, and commercialization of therapeutic products.

SAB Biotherapeutics is a clinical-stage biopharmaceutical development company.

Acticor Biotech is a biopharmaceutical company developing an innovative drug for the treatment in the acute phase of ischemic stroke.

Longeveron is a biotechnology company that focuses on developing cellular therapies for chronic aging-related and life-threatening diseases.

Freeline is a biotechnology company that develops transformative gene therapies for systemic debilitating diseases.

Puma Biotechnology acquires and develops innovative products for the treatment of various forms of cancer.

Arcutis Biotherapeutics is a clinical-stage biopharmaceutical company focused on developing medical dermatology for unmet needs.

Applied Therapeutics uses drug-development approach to target molecules and pathways that has roles in fatal or debilitating diseases.